Global DNA Diagnostics Market Outlook, Trends 2024-2033: An In-Depth Analysis

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

DNA Diagnostics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $34.90 billion In 2028 At A CAGR Of 10.9% :

The DNA diagnostics market size has grown rapidly in recent years. It will grow from $20.90 billion in 2023 to $23.10 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing adoption of genetic testing and molecular diagnostics in clinical practice, rising biomedical research, the increasing number of cancer patients, and the growing use of diagnostics tests.

The DNA diagnostics market size is expected to see rapid growth in the next few years. It will grow to $34.90 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing the prevalence of cancers, increasing demand for standardized diagnostic tests, rising prevalence of genetic disorders, increasing focus on biomarker discovery, rare diseases and orphan drugs, and growth of telemedicine and remote testing. Major trends in the forecast period include the integration of microbiome analysis, integration of blockchain technology, the integration of multiple omics data, non-invasive testing, multi-omics integration, the development of portable and point-of-care DNA diagnostic devices, and next-generation sequencing (NGS).

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15356&type=smp

DNA Diagnostics Market Major Segments
The DNA diagnostics market covered in this report is segmented -

1) By Product Type: Instruments, Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Microarray, In-situ Hybridization, Sequencing Technology, Mass Spectrometry
3) By Application: Oncology, Infectious Diseases Treatment, Myogenic Disorder Treatment, Clinical Diagnostic Confirmation, Prenatal, Pre-Implantation, Other Applications
4) By End User: Point Of Care, Diagnostic Centers, Self-Testing Or Over-The-Counter (OTC)

Key Driver - Rising Prevalence Of Genetic Disorders Growth In DNA Diagnostics

The rising prevalence of genetic disorders is expected to propel the growth of the DNA diagnostics market going forward. Genetic disorders refer to health problems caused by one or more abnormalities in the genome. The rising cases of genetic disorders are due to increased diagnostic capabilities, expanded genetic testing, environmental influences, and consanguinity within populations, leading to a greater understanding and detection of genetic disorders conditions. DNA diagnostics enables the precise identification of genetic disorders through genetic material analysis, facilitating early diagnosis, personalized treatment, and informed family planning decisions. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. An additional 170,000 children between the ages of 1 month and 5 years die as a result of congenital diseases. Therefore, the rising prevalence of genetic disorders is driving the growth of the DNA diagnostics market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15356&type=smp

Prominent Trend - Liquid Biopsy Innovations For Early Cancer Detection

Major companies operating in the DNA diagnostics market are focused on developing innovative products, such as liquid biopsy tests, to detect various types of cancer at an early stage. A liquid biopsy is a minimally invasive medical test that detects and analyzes biomarkers, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes, released into the bloodstream from tumors or other cells. For instance, in May 2023, Laboratory Corporation, a US-based healthcare diagnostics company, launched a new liquid biopsy test called LabCorp Plasma Focus, which identifies targeted therapies for patients with advanced or metastatic solid tumors. This test utilizes genetic sequencing to evaluate circulating cell-free DNA (cfDNA) released by tumor cells, allowing oncologists to personalize and improve patient care through targeted therapy plans.

DNA Diagnostics Market Players
Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc, PerkinElmer Inc, bioMérieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the DNA diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. DNA Diagnostics Market Report Structure
3. DNA Diagnostics Market Trends And Strategies
4. DNA Diagnostics Market - Macro Economic Scenario
5. DNA Diagnostics Market Size And Growth
…..
27. DNA Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.